Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MIRACLE-T2D Montelukast Intervention for Renal, Cardiovascular and Eye Health in Type 2 Diabetes

NCT07685886 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.

NCT NCT07685886
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07685886 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MIRACLE-T2D Montelukast Intervention for Renal, Cardiovascular and Eye Health in Type 2 Diabetes
Lead sponsor
University of Colorado, Denver
Phase
Phase 4
Overall status
Not yet recruiting
Start date
September 1, 2026
Completion date
August 31, 2031
Enrollment
110 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, kidney disease, retinopathy, vascular disease